GPE VIII GP S.a.r.l.

CIK 1764293 · last filed 2024-11-15

GPE VIII GP S.a.r.l. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $1.42B of FWRG on Nov 15, 2024. Across all open-market trades the lifetime net is −$2.58B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $217.8M across reported positions. The firm reports its address in Boston, MA. 34 SEC filings were submitted jointly with GPE VIII GP Limited Partnership.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$217.80M

Companies

2

Total Filings

5

Lifetime Open-Market Net

-$2.58B

Filer Profile

Reported Address

CO ADVENT INTERNATIONAL
800 BOYLSTON STREET
BOSTON, MA 02199

Phone

(617) 951-9400

State of Incorporation

Luxembourg

Related Filers

GPE VIII GP Limited Partnership — 34 joint filings, latest 2025-11-12

ADVENT INTERNATIONAL, L.P. — 33 joint filings, latest 2025-11-12

Advent International GPE VIII, LLC — 21 joint filings, latest 2025-11-12

Advent International GPE VIII-C Limited Partnership — 19 joint filings, latest 2025-11-12

Advent International GPE VIII-E Limited Partnership — 14 joint filings, latest 2024-11-15

Advent International GPE VIII-G Limited Partnership — 14 joint filings, latest 2024-11-15

Advent International GPE VIII-K Limited Partnership — 14 joint filings, latest 2024-11-15

Cypress Investment GP, LLC — 12 joint filings, latest 2025-11-12

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
FWRG	10%+ Owner	19,189,784	$11.35	$217.80M	-$2.22B	4	2024-11-15
Syneos Health, Inc. (SYNH) Delisted	10%+ Owner	6,307,489	$42.98	$271.10M	-$363.82M	1	2021-05-18

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-11-15	FWRG	Sell (S)	−72,000,000	-$1.42B	EDGAR
2023-07-06	FWRG	Sell (S)	−4,500,000	-$73.91M	EDGAR
2023-05-22	FWRG	Sell (S)	−40,250,000	-$622.67M	EDGAR
2022-10-11	FWRG	Sell (S)	−6,750,000	-$99.92M	EDGAR
2021-05-18	Syneos Health, Inc. (SYNH) Delisted	Sell (S)	−4,489,420	-$363.82M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.